Clinical Trial Update: Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab with lenalidomide and dexamethasone in newly diagnosed multiple myeloma patients eligible for stem cell transplant has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2019-07-17